Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Thromboembolism: early-phase trial registry
2 of 10 indexed Thromboembolism trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 2 currently recruiting · #1,724 of 28,707 conditions by registered trial count
Thromboembolism: 10 US clinical trials tracked, 2 recruiting.
Thromboembolism is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is University of Utah, running 2 of these trials.
Enrollment posture brief
Registry condition thromboembolism
OPEN 2 | RECR 20% | LATE 1 | EARLY 3 | RANK #1724 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acral Lentiginous Melanoma (20% recruiting · 5 trials)
Thromboembolism lists 2 open slots (20% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Thromboembolism on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Thromboembolism is recruiting below its size-band peers.
2 of 10 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Thromboembolism research.
University of Utah accounts for 2 of 10 trials (20%). 9 distinct sponsors appear on at least one study for this condition label.
-
Typical Thromboembolism enrolment sits around 86 participants.
Median target enrolment is 86 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.
-
Thromboembolism research is mostly interventional.
8 interventional and 2 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
Kristen Ban
NCT06657924
In Vivo Detection of Circulating Clots in Patients With Thromboembolism
University of Arkansas
NCT05301348
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE
Northwell Health
NCT03581877
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
Medco Health Solutions
NCT00830570
Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery
University of Utah
NCT04305756
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NCT00253669
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
University of Illinois at Chicago
NCT02776566
Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery
University of Utah
NCT06118957
Strategies for Anticoagulation During Venovenous ECMO
Vanderbilt University Medical Center
NCT04997265
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
Memorial Sloan Kettering Cancer Center
NCT00014352
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Thromboembolism records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Thromboembolism trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Thromboembolism page
10 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Thromboembolism trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Utah sponsors the most Thromboembolism trials on record, review their full trial history before evaluating a specific study. See University of Utah's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Thromboembolism condition card totals 10 registered trials; most-linked intervention Enoxaparin; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.